The present invention is directed to bridged aryl piperazine derivatives, pharmaceutical compositions containing them and their use in the treatment of depression and related disorders. The compounds of the present invention are serotonin transport inhibitors and/or modulators of 5HT
1A
.
本发明涉及桥联芳基
哌嗪衍
生物,含有它们的药物组合物以及它们在治疗抑郁症和相关疾病中的用途。本发明的化合物是
血清素转运
抑制剂和/或5HT1A的调节剂。